Literature DB >> 26430241

Correction for Colaianni et al., The myokine irisin increases cortical bone mass.

.   

Abstract

Entities:  

Year:  2015        PMID： 26430241      PMCID： PMC4620910          DOI： 10.1073/pnas.1519137112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  3 in total

1.  FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-κB Activation and CXCL10 Expression.

Authors:  Zheng-Tao Lv; Shuang Liang; Kun Chen; Jia-Ming Zhang; Peng Cheng; Jia-Chao Guo; Qing Yang; Chen-He Zhou; Hui Liao; An-Min Chen
Journal:  Biomed Res Int       Date:  2018-05-30       Impact factor: 3.411

Review 2.  The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity.

Authors:  Hui Li; Fang Wang; Mu Yang; Jiao Sun; Yi Zhao; Dongqi Tang
Journal:  Int J Endocrinol       Date:  2021-03-18       Impact factor: 2.803

3.  Is Preptin a New Bone Metabolism Parameter in Hemodialysis Patients?

Authors:  Małgorzata Kałużna; Krzysztof Pawlaczyk; Krzysztof Schwermer; Krzysztof Hoppe; Aisha Yusuf Ibrahim; Magdalena Czlapka-Matyasik; Elżbieta Wrotkowska; Katarzyna Ziemnicka; Andrzej Oko; Marek Ruchała
Journal:  Life (Basel)       Date:  2021-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.